Straumann Holding AAQS 2024

Straumann Holding AAQS

9

Straumann Holding Udbytterendite

0,68 %

Ticker

STMN.SW

ISIN

CH0012280076

WKN

914326

Straumann Holding har en aktuel AAQS på 9. En høj AAQS kan betragtes som et positivt tegn på, at virksomheden udvikler sig succesfuldt. Investorerne kan forvente, at virksomheden er på rette spor mod at skabe overskud. På den anden side er det vigtigt at betragte AAQS for aktien Straumann Holding i forhold til de opnåede overskud og sammenligne med andre virksomheder i samme branche. En høj AAQS er ikke en absolut garanti for en positiv fremtid. Det er kun på den måde, man kan få et komplet billede af virksomhedens præstationer. For bedre at kunne vurdere virksomhedens udvikling er det vigtigt at betragte AAQS i sammenligning med andre virksomheder i samme branche. Generelt bør investorer altid betragte en virksomheds AAQS i sammenhæng med andre nøgletal som overskud, EBIT, cash flow og andre for at træffe en velbaseret investeringsbeslutning.

Straumann Holding Aktienanalyse

Hvad gør Straumann Holding?

Straumann Holding AG is a global leading company in the fields of implantology and regenerative dentistry. It was founded in 1954 by Dr. Reinhard Straumann and is headquartered in Basel, Switzerland. The company's history began with the development of titanium dental implants, which is still considered the standard in implantology today. Over the following decades, Straumann expanded its portfolio to include other products and services in the field of oral rehabilitation and regenerative dentistry. Straumann's business model is based on collaboration with dentists and dental technicians worldwide. The company offers a wide range of innovative products and services to support them in patient treatment. This includes implants, abutments, regenerative materials such as bone substitutes and membranes, digital solutions for dentists and dental technicians, as well as training programs and clinical support. In addition, the company has expanded its activities in recent years to areas such as cranio-maxillofacial, oral surgery, and orthodontics. In terms of its different divisions, Straumann has three main business areas: implantology, regenerative solutions, and digital solutions. The implantology division includes implant solutions for all indications, from single-tooth implants to cone and volume implants, as well as long-term solutions for the edentulous. Straumann's regenerative solutions support the restoration of oral soft and hard tissues, offering a wide range of products for tissue cultivation and regeneration. Digital solutions provide a variety of tools to improve the workflows of dentists and dental technicians, as well as optimized planning, design, and production of dental restorations. The company operates globally, with subsidiaries in over 30 countries. Straumann has a network of distribution partners to ensure access to its products and services in over 100 countries worldwide. In Switzerland, the company also operates a center for materials research and development, where researchers and engineers focus on the development of new innovative products. Flagship products of Straumann include the SLActive® implant system, which allows for rapid osseointegration due to its special coating, and the Bone Level® implant system, which offers maximum surgical flexibility through its platform switch compatibility. Another important innovation from Straumann is the BoneCeramic® material, a synthetic bone substitute material that has high biocompatibility and integrated porous structures to promote bone regeneration. Overall, Straumann Holding AG is known for its extensive experience in implantology and continuous development of innovative solutions that meet the needs of dentists and dental technicians worldwide. Straumann Holding ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Ofte stillede spørgsmål om Straumann Holding aktien

Aktiespareplaner tilbyder en attraktiv mulighed for investorer at opbygge formue på lang sigt. En af de største fordele er den såkaldte cost-average-effekt: Ved regelmæssigt at investere et fast beløb i aktier eller aktiefonde, køber man automatisk flere andele, når priserne er lave, og færre, når de er høje. Dette kan føre til en mere fordelagtig gennemsnitspris per andel over tid. Desuden giver aktiespareplaner også småinvestorer adgang til dyre aktier, da de kan deltage med små beløb. Den regelmæssige investering fremmer også en disciplineret investeringsstrategi og hjælper med at undgå følelsesladede beslutninger, som impulsiv køb eller salg. Derudover drager investorer fordel af den potentielle værdistigning af aktierne samt af udbytteudlodninger, der kan geninvesteres, hvilket forstærker renters rente effekten og dermed væksten af det investerede kapital.

Andere Kennzahlen von Straumann Holding

Vores aktieanalyse af Straumann Holding Omsætning-aktien indeholder vigtige finansielle nøgletal som omsætning, profit, P/E-ratioen, P/S-ratioen, EBIT samt informationer om udbytte. Desuden ser vi på aspekter som aktier, markedskapitalisering, gæld, egenkapital og forpligtelser hos Straumann Holding Omsætning. Hvis du søger mere detaljerede oplysninger om disse emner, tilbyder vi på vores undersider omfattende analyser: